Home > Cashflow Statement > SYNCOM FORMULATIONS (INDIA)

SYNCOM FORMULATIONS (INDIA)
Cash Flow from Operating Activities

    Back to Cashflow Statement
SYNCOM FORMULATIONS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

SYNCOM FORMULATIONS (INDIA) Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2017
Cash Flow from Operating Activities ₹23 Cr₹-5.96 Cr₹11 Cr₹16 Cr₹14 Cr

What is the latest Cash Flow from Operating Activities ratio of SYNCOM FORMULATIONS (INDIA) ?

The latest Cash Flow from Operating Activities ratio of SYNCOM FORMULATIONS (INDIA) is ₹23 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Operating Activities
Mar2025₹23 Cr
Mar2024₹-5.96 Cr
Mar2023₹11 Cr
Mar2022₹16 Cr
Mar2017₹14 Cr

How is Cash Flow from Operating Activities of SYNCOM FORMULATIONS (INDIA) Trending?

Years Cash Flow from Operating Activities % Change
Mar2025 ₹23 Cr
Positive
Mar2024 ₹-5.96 Cr
Negative
Mar2023 ₹11 Cr
-35.52
Mar2022 ₹16 Cr
17.98
Mar2017 ₹14 Cr -

Compare Cash Flow from Operating Activities of peers of SYNCOM FORMULATIONS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA) ₹1,273.7 Cr 4.2% -3.1% -26.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,615.0 Cr 4% -4.9% -2.3% Stock Analytics
DIVIS LABORATORIES ₹159,943.0 Cr 1.1% -9.3% 9.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹133,336.0 Cr -1.3% -3.7% 24% Stock Analytics
CIPLA ₹107,499.0 Cr 1.5% -9.3% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹103,590.0 Cr 5% -0.1% 3.3% Stock Analytics


SYNCOM FORMULATIONS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SYNCOM FORMULATIONS (INDIA)

4.2%

-3.1%

-26.1%

SENSEX

3.5%

-1.7%

7.8%


You may also like the below Video Courses